Application of pharmacogenomics and bioinformatics to exemplify the utility of human ex vivo organoculture models in the field of precision medicine-Reference-Cited by-同舟云学术

Application of pharmacogenomics and bioinformatics to exemplify the utility of human ex vivo organoculture models in the field of precision medicine

Published:2019-12-20 Issue:12 Volume:14 Page:e0226564
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cowan Karen^ORCID,Macluskie Graeme,Finch Michael,Palmer Colin N. A.^ORCID,Hair Jane,Bylesjo Max,Lynagh Sarah,Brankin Pamela,McNeil Marian,Low Carolyn,Mallinson David,Gourlay Elaine M.,Child Hannah,Cheyne Linda,Bunton David C.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Perspective: Does personalized medicine hold the future for medicine?;AA Agyeman;J Pharm Bioallied Sci

2. Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value;Y Chen;J Pers Med,2016

3. How to improve RD productivity: The pharmaceutical industry’s grand challenge;SM Paul;Nature Reviews Drug Discovery,2010

4. Personalized medicine: Time for one-person trials;NJ Schork;Nature. Nature Publishing Group,2015

5. Quantifying factors for the success of stratified medicine;MR Trusheim;Nat Rev Drug Discov,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining explainable machine learning, demographic and multi-omic data to inform precision medicine strategies for inflammatory bowel disease;PLOS ONE;2022-02-23

2. Combining explainable machine learning, demographic and multi-omic data to identify precision medicine strategies for inflammatory bowel disease;2021-03-05